反応式
[Br:1][C:2]1[C:3]([NH:21][C:22]2[CH:26]=[C:25]([CH:27]3[CH2:29][CH2:28]3)[NH:24][N:23]=2)=[N:4][C:5]([C:8]2[S:12][C:11]([S:13]([NH:16][C:17]([CH3:20])([CH3:19])[CH3:18])(=[O:15])=[O:14])=[CH:10][CH:9]=2)=[N:6][CH:7]=1.[CH3:30][C:31](OC(C)=O)=[O:32]>C1COCC1.O>[C:31]([N:24]1[C:25]([CH:27]2[CH2:28][CH2:29]2)=[CH:26][C:22]([NH:21][C:3]2[C:2]([Br:1])=[CH:7][N:6]=[C:5]([C:8]3[S:12][C:11]([S:13]([NH:16][C:17]([CH3:19])([CH3:20])[CH3:18])(=[O:14])=[O:15])=[CH:10][CH:9]=3)[N:4]=2)=[N:23]1)(=[O:32])[CH3:30]参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
To 5-(5-bromo-4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)-N-tert-butylthiophene-2-sulfonamide (1.6 g, 3.21 mmol, 1.0 eq) in THF/H2O (30 mL/15 mL), Ac2O (0.64 g, 6.42 mmol, 2.0 eq) was added dropwise. The reaction mixture was stirred at room temperature for 1 h. The reaction mixture was filtered to afford compound 5-(4-(1-acetyl-5-cyclopropyl-1H-pyrazol-3-ylamino)-5-bromopyrimidin-2-yl)-N-tert butylthiophene-2-sulfonamide (1.6 g, 92%). LC-MS (m/z)=539 [M+H]+
後処理
- filtrationThe reaction mixture was filtered
出典と根拠
- ORDレコード
- ord-8f9f625f22874502bf2efd72fe0a3af9
- 出典データセット
- uspto-grants-2016_08
- 特許番号
- US09422271B2
関連ノート
読み込み中…